Goldman Sachs’s Pfizer PFE Stock Holding History

Goldman Sachs’s Portfolio PFE Stock Details PFE Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$735M	Buy	30,341,914 +4,789,757	+19%	+$116M	0.1%	161
2025 Q1	$647M	Buy	25,552,157 +8,233,390	+48%	+$209M	0.1%	162
2024 Q4	$459M	Sell	17,318,767 -8,507,851	-33%	-$226M	0.07%	211
2024 Q3	$747M	Sell	25,826,618 -9,090,121	-26%	-$263M	0.12%	129
2024 Q2	$977M	Buy	34,916,739 +12,569,585	+56%	+$352M	0.17%	90
2024 Q1	$620M	Sell	22,347,154 -1,722,272	-7%	-$47.8M	0.11%	150
2023 Q4	$693M	Sell	24,069,426 -511,767	-2%	-$14.7M	0.13%	133
2023 Q3	$815M	Sell	24,581,193 -1,627,801	-6%	-$54M	0.17%	86
2023 Q2	$961M	Buy	26,208,994 +2,397,511	+10%	+$87.9M	0.21%	65
2023 Q1	$972M	Sell	23,811,483 -1,172,040	-5%	-$47.8M	0.22%	58
2022 Q4	$1.28B	Buy	24,983,523 +3,053,993	+14%	+$156M	0.31%	36
2022 Q3	$960M	Buy	21,929,530 +63,669	+0.3%	+$2.79M	0.24%	56
2022 Q2	$1.15B	Buy	21,865,861 +2,033,150	+10%	+$107M	0.29%	41
2022 Q1	$1.03B	Buy	19,832,711 +2,090,429	+12%	+$108M	0.22%	54
2021 Q4	$1.05B	Sell	17,742,282 -890,845	-5%	-$52.6M	0.21%	56
2021 Q3	$801M	Buy	18,633,127 +3,225,374	+21%	+$139M	0.17%	85
2021 Q2	$603M	Sell	15,407,753 -2,100,986	-12%	-$82.3M	0.14%	113
2021 Q1	$634M	Buy	17,508,739 +1,122,647	+7%	+$40.7M	0.16%	89
2020 Q4	$603M	Buy	16,386,092 +1,086,857	+7%	+$40M	0.16%	89
2020 Q3	$561M	Sell	15,299,235 -15,891,503	-51%	-$583M	0.16%	84
2020 Q2	$1.02B	Sell	31,190,738 -1,935,663	-6%	-$63.3M	0.31%	37
2020 Q1	$1.08B	Sell	33,126,401 -11,447,342	-26%	-$374M	0.38%	32
2019 Q4	$1.75B	Buy	44,573,743 +3,483,651	+8%	+$136M	0.44%	21
2019 Q3	$1.48B	Buy	41,090,092 +922,263	+2%	+$33.1M	0.43%	24
2019 Q2	$1.74B	Sell	40,167,829 -12,798,527	-24%	-$554M	0.5%	17
2019 Q1	$2.25B	Buy	52,966,356 +14,149,127	+36%	+$601M	0.68%	11
2018 Q4	$1.69B	Sell	38,817,229 -2,144,550	-5%	-$93.6M	0.54%	18
2018 Q3	$1.81B	Buy	40,961,779 +669,067	+2%	+$29.5M	0.47%	16
2018 Q2	$1.46B	Sell	40,292,712 -9,295,714	-19%	-$337M	0.4%	21
2018 Q1	$1.76B	Sell	49,588,426 -3,174,409	-6%	-$113M	0.45%	19
2017 Q4	$1.91B	Buy	52,762,835 +3,235,761	+7%	+$117M	0.46%	18
2017 Q3	$1.77B	Buy	49,527,074 +1,810,974	+4%	+$64.7M	0.43%	17
2017 Q2	$1.6B	Buy	47,716,100 +6,449,202	+16%	+$217M	0.41%	21
2017 Q1	$1.41B	Buy	41,266,898 +3,447,797	+9%	+$118M	0.38%	21
2016 Q4	$1.23B	Buy	37,819,101 +4,664,706	+14%	+$152M	0.35%	21
2016 Q3	$1.12B	Sell	33,154,395 -5,184,718	-14%	-$176M	0.34%	21
2016 Q2	$1.35B	Sell	38,339,113 -67,439,472	-64%	-$2.37B	0.44%	11
2016 Q1	$3.14B	Buy	105,778,585 +53,778,542	+103%	+$1.59B	1.03%	3
2015 Q4	$1.68B	Buy	52,000,043 +12,726,485	+32%	+$411M	0.53%	11
2015 Q3	$1.23B	Buy	39,273,558 +228,216	+0.6%	+$7.17M	0.42%	14
2015 Q2	$1.31B	Sell	39,045,342 -26,051,258	-40%	-$873M	0.41%	17
2015 Q1	$2.26B	Buy	65,096,600 +20,509,267	+46%	+$714M	0.73%	4
2014 Q4	$1.39B	Buy	44,587,333 +4,950,747	+12%	+$154M	0.44%	13
2014 Q3	$1.17B	Buy	39,636,586 +3,587,101	+10%	+$106M	0.37%	17
2014 Q2	$1.07B	Buy	36,049,485 +1,983,837	+6%	+$58.9M	0.34%	28
2014 Q1	$1.09B	Sell	34,065,648 -2,057,925	-6%	-$66.1M	0.36%	26
2013 Q4	$1.11B	Buy	36,123,573 +549,169	+2%	+$16.8M	0.36%	25
2013 Q3	$1.02B	Sell	35,574,404 -3,003,337	-8%	-$86.3M	0.38%	19
2013 Q2	$1.08B	Buy	+38,577,741	New	+$1.08B	0.42%	15